Lactated Ringers And Dextrose Injection, Solution
NDC Package 65219-243-50

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Lactated Ringers And Dextrose (sodium chloride, sodium lactate, potassium chloride, calcium chloride, and dextrose monohydrate) injection is these solutions are indicated for parenteral replacement of extracellular losses of fluid and electrolytes, with minimal carbohydrate calories, as required by the clinical condition of the patient. This formulation utilizes a injection, solution delivery system. Marketed by Fresenius Kabi Usa, Llc, this product is identified by NDC 65219-243 and is authorized under FDA application ANDA210332.

Identification & Billing

NDC Package Code
65219-243-50
Package Description
20 BAG in 1 CASE / 500 mL in 1 BAG (65219-243-01)
Product Code
65219-243
11-Digit Billing Format
65219024350
RxNorm Crosswalk
  • RxCUI: 847627 - lactated Ringers with dextrose 5 % Injectable Solution
  • RxCUI: 847627 - calcium chloride 0.2 MG/ML / glucose 50 MG/ML / potassium chloride 0.3 MG/ML / sodium chloride 6 MG/ML / sodium lactate 3.1 MG/ML Injectable Solution
  • RxCUI: 847627 - calcium chloride 0.2 MG/ML / glucose 50 MG/ML / K+ chloride 0.3 MG/ML / NaCl 6 MG/ML / sodium lactate 3.1 MG/ML Injectable Solution
  • RxCUI: 847627 - calcium chloride 0.2 MG/ML / glucose 50 MG/ML / Pot chloride 0.3 MG/ML / NaCl 6 MG/ML / sodium lactate 3.1 MG/ML Injectable Solution
  • RxCUI: 847627 - calcium chloride 20 MG / potassium chloride 30 MG / sodium chloride 600 MG / sodium lactate 310 MG per 100 ML Ringers with dextrose 5 % Injectable Solution

Clinical Specifications

Proprietary Name
Lactated Ringers And Dextrose
Non-Proprietary Name
Sodium Chloride, Sodium Lactate, Potassium Chloride, Calcium Chloride, And Dextrose Monohydrate
Substance Name
Calcium Chloride; Dextrose Monohydrate; Potassium Chloride; Sodium Chloride; Sodium Lactate
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
Pharmacologic Class
Usage Information
These solutions are indicated for parenteral replacement of extracellular losses of fluid and electrolytes, with minimal carbohydrate calories, as required by the clinical condition of the patient.

Regulatory & Marketing

Labeler Name
Fresenius Kabi Usa, Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA210332
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-28-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 65219-243-50 identifies a specific commercial package of 20 bag in 1 case / 500 ml in 1 bag (65219-243-01) of Lactated Ringers And Dextrose, a human prescription drug labeled by Fresenius Kabi Usa, Llc. This injection, solution is formulated for intravenous use and contains calcium chloride; dextrose monohydrate; potassium chloride; sodium chloride; sodium lactate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Fresenius Kabi Usa, Llc on March 28, 2022. The current certification is valid through December 31, 2026.

How is this Fresenius Kabi Usa, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 65219024350. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
65219-243-50
11-Digit CMS (5-4-2)
65219-0243-50

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.